v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Total Thermo Fisher Scientific Inc. Shareholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2024 $ 120              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 8              
Other comprehensive income/(loss) 6              
Contributions from (distributions to) noncontrolling interests (8)              
Ending balance at Jun. 28, 2025 126              
Common stock, beginning balance (in shares) at Dec. 31, 2024     444,000,000          
Beginning balance at Dec. 31, 2024 49,551 $ 49,584 $ 444 $ 17,962 $ 53,102 $ (19,226) $ (2,697) $ (33)
Treasury stock beginning balance (in shares) at Dec. 31, 2024           63,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000          
Issuance of shares under stock plans 90 90 $ 1 115   $ (26)    
Stock-based compensation 156 156   156        
Purchases of company common stock (in shares)           4,000,000    
Purchases of company common stock (2,000) (2,000)       $ (2,000)    
Dividends declared (325) (325)     (325)      
Net income/(loss) 3,122 3,124     3,124     (2)
Other comprehensive income/(loss) (99) (99)         (99)  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Excise tax from stock repurchases (17) (17)       (17)    
Common stock, ending balance (in shares) at Jun. 28, 2025     444,000,000          
Ending balance at Jun. 28, 2025 50,476 50,512 $ 444 18,232 55,901 $ (21,269) (2,797) (35)
Treasury stock ending balance (in shares) at Jun. 28, 2025           67,000,000    
Beginning balance at Mar. 29, 2025 128              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 3              
Other comprehensive income/(loss) 3              
Contributions from (distributions to) noncontrolling interests (8)              
Ending balance at Jun. 28, 2025 126              
Common stock, beginning balance (in shares) at Mar. 29, 2025     444,000,000          
Beginning balance at Mar. 29, 2025 49,357 49,390 $ 444 18,111 54,447 $ (21,269) (2,343) (33)
Treasury stock beginning balance (in shares) at Mar. 29, 2025           67,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans 40 40   41   $ (1)    
Stock-based compensation 81 81   81        
Dividends declared (163) (163)     (163)      
Net income/(loss) 1,615 1,617     1,617     (2)
Other comprehensive income/(loss) (454) (453)         (453)  
Contributions from (distributions to) noncontrolling interests 0              
Common stock, ending balance (in shares) at Jun. 28, 2025     444,000,000          
Ending balance at Jun. 28, 2025 50,476 50,512 $ 444 18,232 55,901 $ (21,269) (2,797) (35)
Treasury stock ending balance (in shares) at Jun. 28, 2025           67,000,000    
Beginning balance at Dec. 31, 2025 122              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 9              
Other comprehensive income/(loss) (2)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending balance at Jun. 27, 2026 121              
Common stock, beginning balance (in shares) at Dec. 31, 2025     445,000,000          
Beginning balance at Dec. 31, 2025 $ 53,415 53,407 $ 445 18,563 59,156 $ (22,309) (2,448) 7
Treasury stock beginning balance (in shares) at Dec. 31, 2025 68,938,831         69,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000          
Issuance of shares under stock plans $ 118 118 $ 1 142   $ (24)    
Stock-based compensation 165 165   165        
Purchases of company common stock (in shares)           7,000,000    
Purchases of company common stock (4,000) (4,000)       $ (4,000)    
Dividends declared (349) (349)     (349)      
Net income/(loss) 3,388 3,387     3,387     1
Other comprehensive income/(loss) (12) (12)         (12)  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Excise tax from stock repurchases (38) (38)       (38)    
Common stock, ending balance (in shares) at Jun. 27, 2026     446,000,000          
Ending balance at Jun. 27, 2026 $ 52,686 52,679 $ 446 18,870 62,194 $ (26,370) (2,460) 7
Treasury stock ending balance (in shares) at Jun. 27, 2026 75,926,613         76,000,000    
Beginning balance at Mar. 28, 2026 $ 121              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 4              
Other comprehensive income/(loss) 4              
Contributions from (distributions to) noncontrolling interests (7)              
Ending balance at Jun. 27, 2026 121              
Common stock, beginning balance (in shares) at Mar. 28, 2026     445,000,000          
Beginning balance at Mar. 28, 2026 51,940 51,934 $ 445 18,713 60,632 $ (25,360) (2,497) 7
Treasury stock beginning balance (in shares) at Mar. 28, 2026           74,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans 74 74   75   $ (1)    
Stock-based compensation 82 82   82        
Purchases of company common stock (in shares)           2,000,000    
Purchases of company common stock (1,000) (1,000)       $ (1,000)    
Dividends declared (174) (174)     (174)      
Net income/(loss) 1,737 1,736     1,736     1
Other comprehensive income/(loss) 37 37         37  
Contributions from (distributions to) noncontrolling interests 0              
Excise tax from stock repurchases (9) (9)       (9)    
Common stock, ending balance (in shares) at Jun. 27, 2026     446,000,000          
Ending balance at Jun. 27, 2026 $ 52,686 $ 52,679 $ 446 $ 18,870 $ 62,194 $ (26,370) $ (2,460) $ 7
Treasury stock ending balance (in shares) at Jun. 27, 2026 75,926,613         76,000,000